Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
Creator Idrissou et al.
Author Malick Bio Idrissou
Author Alexandre Pichard
Author Bryan Tee
Author Tibor Kibedi
Author Sophie Poty
Author Jean-Pierre Pouget
Abstract Auger electron emitters (AEEs) are attractive tools in targeted radionuclide therapy to specifically irradiate tumour cells while sparing healthy tissues. However, because of their short range, AEEs need to be brought close to sensitive targets, particularly nuclear DNA, and to a lower extent, cell membrane. Therefore, radioimmunoconjugates (RIC) have been developed for specific tumour cell targeting and transportation to the nucleus. Herein, we assessed, in A-431CEA-luc and SK-OV-31B9 cancer cells that express low and high levels of HER2 receptors, two 111In-RIC consisting of the anti-HER2 antibody trastuzumab conjugated to NLS or TAT peptides for nuclear delivery. We found that NLS and TAT peptides improved the nuclear uptake of 111In-trastuzumab conjugates, but this effect was limited and non-specific. Moreover, it did not result in a drastic decrease of clonogenic survival. Indium-111 also contributed to non-specific cytotoxicity in vitro due to conversion electrons (30% of the cell killing). Comparison with [125I]I-UdR showed that the energy released in the cell nucleus by increasing the RIC's nuclear uptake or by choosing an AEE that releases more energy per decay should be 5 to 10 times higher to observe a significant therapeutic effect. Therefore, new Auger-based radiopharmaceuticals need to be developed.
Publication Pharmaceutics
Volume 13
Issue 7
Pages 980
Date 2021-06-29
Journal Abbr Pharmaceutics
Language eng
DOI 10.3390/pharmaceutics13070980
ISSN 1999-4923
Short Title Targeted Radionuclide Therapy Using Auger Electron Emitters
Library Catalog PubMed
Extra Number: 7 PMID: 34209637 PMCID: PMC8309076
Tags Auger electrons, first-last-corresponding, NLS peptide, nuclear localisation sequence, original, radionuclide therapy, Scientific, TAT peptide, top
Date Added 2023/11/23 - 12:44:38
Date Modified 2024/12/15 - 12:39:05
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés